Monday 27 August 2018

Weight-loss pill hailed as 'holy grail' in fight against obesity

US study of 12,000 people shows drug lorcaserin does not increase risk of serious heart problems

A weight-loss pill has been hailed as a potential “holy grail” in the fight against obesity after a major study showed it did not increase the risk of serious heart problems.

Researchers say lorcaserin is the first weight-loss drug to be deemed safe for heart health with long-term use. Taken twice a day, the drug is an appetite suppressant which works by stimulating brain chemicals to induce a feeling of fullness.

Continue reading...

from World news | The Guardian https://ift.tt/2Luj9FT

No comments:

Post a Comment

Resistance to daptomycin in near-untreatable superbug caused by a different antibiotic, study finds

‘Surprising’ finding by Australian-led study is first recorded instance of an antibiotic causing resistance to one in a different class The...